Nainesh Parikh

Dr. Abi-Jaoudeh is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and completed internship and residency at the University of Laval in Québec, Canada a fellowship in interventional radiology at the University of Virginia in Charlottesville, Va. She then joined National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of Clinical research of the department of Radiology and in 2020 she became the chief of Interventional radiology section. She is principal investigator on multiple Phase I, II and III trials.
She has authored multiple manuscripts and submitted two patents related to imaging technology in the angiography suite. Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease. Her goal is to grow a translational research program to improve UCI patient care and outcome.
Dr Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology. She has served as deputy editor of the Journal of Vascular and Interventional Radiology and on the scientific committee of the Society of Interventional Radiology annual meeting and the chair of the clinical trials and registries committees.

Dr. Siddharth Padia is an Interventional Radiologist and Professor of Radiology at the David Geffen School of Medicine at UCLA. He is also director of Interventional Radiology at UCLA Santa Monica. His areas of clinical expertise and research interests include liver cancer, interventional oncology, vascular disease and portal hypertension.

Dr. Padia earned his medical degree from Johns Hopkins University School of Medicine. After completing his transitional internship at The University of Hawaii in Honolulu, Dr. Padia began his residency in diagnostic radiology at the Cleveland Clinic in Ohio and graduated as Chief Resident. After spending many years practicing interventional radiology at the University of Washington, Dr. Padia joined the faculty at UCLA in 2016.

Dr. Padia specializes in advanced minimally-invasive technologies to treat liver cancer by infusing highly radioactive particles (Yttrium-90) into the liver, and has treated over 800 patients with this therapy. Due to his expertise in this field, he is the primary author of the national treatment guidelines for Yttrium 90 radioembolization, and is a director of the national annual course to educate physicians on this therapy. Recently, he has helped develop novel treatments for patients suffering from knee arthritis, specifically genicular artery embolization. He has recently led and completed the largest US clinical trial to date for genicular artery embolization, and is embarking on multiple trials for embolization of joint pain.

Dr. Merve Ozen is a board-certified diagnostic and interventional radiologist and Associate Professor of Radiology at Mayo Clinic in Phoenix, Arizona. She has authored numerous peer-reviewed publications on advanced interventional techniques and anatomical insights and is a frequent presenter at national and international meetings, including the Society of Interventional Radiology (SIR).

Her clinical expertise centers on interventional oncology—particularly tumor ablation and embolization. Dr. Ozen’s academic contributions span invited lectures, panel moderation, and program coordination, with a strong commitment to trainee education and early-career mentorship. She is also recognized for pioneering innovative educational initiatives that bridge clinical practice and professional development.

Robert J. Lewandowski, M.D., FSIR, is a Professor of Radiology, Medicine, and Surgery in the Feinberg School of Medicine at Northwestern University. He serves as the Director of Interventional Oncology at the Northwestern University Robert H. Lurie Comprehensive Cancer Center. Dr. Lewandowski joined the staff at Northwestern in 2006 upon completion of his fellowship training in Vascular and Interventional Radiology. Dr. Lewandowski is a practicing interventional radiologist who specializes in liver-directed therapy. Based on his clinical oncology program, he has authored or co-authored > 200 articles for peer-reviewed journals on the application of liver-directed therapies for patients with gastrointestinal malignancies. Dr. Lewandowski also performs pre-clinical oncology research in the Northwestern University Interventional Oncology Laboratory and Center for Translational Imaging. In this capacity, he is developing and evaluating novel oncology therapeutics, delivery mechanisms, and imaging modalities. Dr. Lewandowski’s work has been supported by the National Institute of Health, American Cancer Society, the Society of Interventional Radiology Foundation, and through industry collaboration via the investigator-initiated trial mechanism.

Dr. Sarbajit Mukherjee is the Chief of Gastrointestinal Medical Oncology at Miami Cancer Institute in Miami, FL. Dr. Mukherjee’s current work focuses on novel clinical trials in GI malignancies. He has conducted multiple investigator-initiated clinical trials as a principal investigator. Dr. Mukherjee has received peer-reviewed grants from the Department of Defense, National Comprehensive Cancer Network (NCCN), and North American Neuroendocrine Tumor Society. He has presented at many national and international conferences and has been published in high-impact journals like Nature Medicine and the Journal of Clinical Oncology. He has served on grant review panels through the NIH (National Institutes of Health) and the US FDA.

Dr. Mukherjee co-chairs the GI clinical trial working group at the Hoosier Cancer Research Network. He also serves as a board member at the Esophageal Cancer Action Network. Dr. Mukherjee served the American Society of Clinical Oncology (ASCO) as a member of the Trainee Council Working Group, the Clinical Practice Guidelines Committee, and the Professional Development Committee. He also served on multiple guidelines panels for ASCO, NCCN and the International Society of the Diseases of the Esophagus. He has received many awards, including membership in Alpha Omega Alpha Medical Honor Society and the Gold Humanism Honor Society. Dr. Mukherjee is invested in teaching and mentoring his junior colleagues and organizing and moderating educational and scientific meetings.

William S. Rilling, MD, FSIR, is a Tenured Professor of Radiology and Surgery at the Medical College of Wisconsin. He completed his diagnostic radiology residency at the Medical College of Wisconsin and his fellowship in Vascular and Interventional Radiology at Northwestern University in Chicago in 1996. He has been practicing at the Medical College of Wisconsin since 1996 and is the Vice Chair of Clinical Operations in Radiology and is also the former Division Chief of Vascular and Interventional Radiology, a role he held for 14 years.

Dr. Rilling has served on the Executive Council for the Society of Interventional Radiology (SIR), the Board of Directors for World Congress of Interventional Oncology (WCIO), SIR Foundation, and Society of Interventional Oncology (SIO). As Education Councilor for SIR, he co-directed the first three professional education meetings dedicated to Interventional Oncology, beginning in 2002. He has also served as the annual meeting chair for both SIR and WCIO and is the past-president for the Society of Interventional Oncology (SIO). He has served as local and national principal investigator for several important IO trials and is currently active as a consultant for several companies working to improve outcomes in IO.

Scott Genshaft, MD, is a Professor of Radiology in the Division of Interventional Radiology at the David Geffen School of Medicine at UCLA. His clinical and academic practice focuses on minimally invasive, image-guided therapies for thoracic malignancies, painful bone and soft-tissue metastases, and musculoskeletal disease, including genicular artery embolization for knee osteoarthritis.

Dr. Genshaft has been a leader in UCLA’s thoracic interventional oncology program, with extensive experience in image-guided thermal ablation. He was lead author of the SIR position statement and quality improvement document on lung ablation. His research has included clinical investigation of image-guided ablation for pulmonary malignancies and painful metastatic disease, as well as prospective studies evaluating genicular artery embolization for knee osteoarthritis.

He also leads the expansion of outpatient and community-based interventional radiology services across UCLA’s regional network, with an emphasis on bringing advanced oncologic, musculoskeletal, and palliative procedures closer to patients. He is actively involved in resident and fellow education and has lectured nationally and internationally on interventional oncology and emerging image-guided therapies.

Outside of work, Scott enjoys traveling with his wife and two sons.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Wertheim Cancer Institute and Co-Director of the Radiopharmaceutical Therapy Program. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. Dr. Kaiser joined Wertheim Cancer Institute in 2020 from the University of Maryland Department of Radiation Oncology, where he served as Fellowship Director as well as Director of the Integrative Wellness Program.

Dr. McClure is a board-certified interventional radiologist and urologist whose expertise is focused on image-guided therapy and minimally invasive treatment of urologic disease. Dr. McClure is Director of Focal Therapy and Interventional Urology at Weill Cornell Medicine. His research interests include improved diagnosis and imaging for prostate cancer, focal therapy for prostate cancer, renal mass biopsy and ablation, and prostate artery embolization.

Dr. Jason Levy, MD, is a board-certified Interventional Radiologist at Northside Hospital in Atlanta. He received his medical degree from NYU School of Medicine and completed both his diagnostic radiology residency and interventional radiology fellowship at the Mallinckrodt Institute of Radiology.
Dr. Levy’s clinical and research expertise centers on Interventional Oncology, with a particular focus on musculoskeletal ablative therapies and liver-directed therapies. He served as the lead author of the OPUS One trial — the largest prospective musculoskeletal ablation study ever conducted. An internationally recognized speaker, he has lectured extensively on interventional oncology worldwide. He is an active member and Fellow of the Society of Interventional Radiology (SIR).